Delegation visit ahead of patent law report.
A surge in taxi fares earlier led Maharashtra govt to set up committee to recommend prices for these players
More lucrative routinely prescribed drugs are at higher risk of failing quality standards
'As for tricky relations with China, India needs less of summitry type event management and more anticipatory analysis and management of events,' says Ambassador Jaimini Bhagwati.
A day before he committed suicide, former Corporate Affair DG B K Bansal had visited the Central Bureau of Investigation headquarters to submit Income Tax certificate showing that his son Yogesh had disclosed over Rs 2.38 crore of unaccounted income to tax authorities.
Roadblocks ahead as these medicines could face new clinical tests, more scrutiny
But Raju has not discarded his first love, real estate.
Thailand expressed interest in the Indian defence industry and its experience and expertise in the field of defence R&D and production. Modi welcomed Thai investments in India in the potential areas under the 'Make in India' initiative, especially in the manufacturing sector, infrastructure development, tourism and hospitality facilities.
In the university category, IISc stood first, followed by JNU and BHU.
'Pay-for-delay' settlements between drug patent-holders and generics manufacturers to delay the launch of cheaper generic medicine are increasingly being scrutinised by antitrust regulators
The FDA had imposed a ban on the company's Waluj plant in May.
'If she contests it, then these people will have to fight it in court.'
'Chamling's legacy is toxic.' '7 out of 10 teenagers in Sikkim abuse drugs.' 'The youth are dying and the future looks bleak.'
An International Policy Network report in 2010 found that seven per cent of drugs bought from wholesale traders were substandard, and 3.6 per cent of the drugs from traders contained no active ingredient whatsoever.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
Sikkim's new chief minister will have to achieve growth without compromising nature.
The Philippines launches probe after Sanofi reveals WHO-approved dengvaxia - a dengue vaccine - aggravates symptoms in some cases.
The number of cases being admitted and investigated by the Competition Commission of India has fallen drastically in recent years.
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
India is not so keen to co-operate with the US on IPR related probe.
In 2010, Abbott acquired both the pharmaceutical business of Solvay, which had a presence in India, and Piramal Healthcare Solutions, which was part of Piramal Group.
It hopes to turn around Ranbaxy within four years of closing the deal by improving efficiency and resolving all regulatory issues
'The failures of private businessmen have set back the process of market-oriented reform, though that is the only way forward,' argues T N Ninan.
Exports from Ranbaxy plants at Toansa and Dewas to Europe will remain suspended as probes are continuing even as Indian authorities have withdrawn the certification of manufacturing standards from one of the units, European health regulator EMA said today.
Seeking cooperation from the public to fight the pandemic, the Union health ministry officials said there was no need to panic. They also said not everyone needs to wear masks and that following social distancing is more important to prevent the spread of COVID-19.
The unilateral pressure by US administration on India, at the behest of US Business Associations lobby through US International Trade Commission investigations and request to USTR to enlist India under Priority Foreign Country under Special 301 review, lacks legitimacy under WTO framework, the signatories to the letter said.
FIFA president blasts critics, says salary not decided.
Dilip Shanghvi founded Sun Pharma in 1983.
We present our alphabet of 2020, pulling in everything you'll remember about this year we'd rather forget.
Beleaguered liquor baron Vijay Mallya on Wednesday announced he will retire as chairman of Sanofi India and will not seek reelection as a director of the drug maker.
A glance back at some of the important ups and down Indian Inc faced in 2018.
In 2013, Daiichi had launched the arbitration proceedings in Singapore.
Tamil film Thani Oruvan is perfectly executed, says S Saraswathi.
Out of nearly 30 public sector undertakings and assets under 'strategic sale' plan, only the ONGC-HPCL plan has been completed
Raghuveer Nayak, an Indian-American multi-millionaire, was sentenced to two years in prison and fined $500,000 in a decade-long medical scam by a federal judge in Chicago on Monday.
Senior police officers were among 13 people killed on Monday when a Taliban suicide bomber blew himself up targeting them during a protest rally outside Pakistan's Punjab assembly in Lahore that also wounded 60 others.
Sebi first began looking into the matter last month.
.jpg)
The company has been reported to be retrenching staff.
The S&P BSE Sensex ended the session at 25,342, up 3 points while the Nifty50 closed at 7,738 points.
